These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 1945284)
21. Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy. Khawly JA; Saloupis P; Hatchell DL; Machemer R Graefes Arch Clin Exp Ophthalmol; 1991; 229(5):464-7. PubMed ID: 1937080 [TBL] [Abstract][Full Text] [Related]
22. Improvement in efficacy of corticosteroid therapy in an animal model of proliferative vitreoretinopathy by pretreatment. Chandler DB; Hida T; Sheta S; Proia AD; Machemer R Graefes Arch Clin Exp Ophthalmol; 1987; 225(4):259-65. PubMed ID: 3653718 [TBL] [Abstract][Full Text] [Related]
23. Antiproliferative effect of retinoic acid in intravitreous silicone oil in an animal model of proliferative vitreoretinopathy. Araiz JJ; Refojo MF; Arroyo MH; Leong FL; Albert DM; Tolentino FI Invest Ophthalmol Vis Sci; 1993 Mar; 34(3):522-30. PubMed ID: 8449673 [TBL] [Abstract][Full Text] [Related]
24. Proliferative vitreo-retinal disorders: experimental models in vivo and in vitro. Martini B Acta Ophthalmol Suppl (1985); 1992; (201):1-63. PubMed ID: 1322004 [TBL] [Abstract][Full Text] [Related]
39. Quantitative assessment of growth stimulating activity of the vitreous during PVR. Yang CM; Cousins SW Invest Ophthalmol Vis Sci; 1992 Jul; 33(8):2436-42. PubMed ID: 1634341 [TBL] [Abstract][Full Text] [Related]
40. Induction of posterior vitreous detachment in rabbits by intravitreal injection of tissue plasminogen activator following cryopexy. Hesse L; Nebeling B; Schroeder B; Heller G; Kroll P Exp Eye Res; 2000 Jan; 70(1):31-9. PubMed ID: 10644418 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]